Journal of Medicinal Chemistry p. 352 - 356 (1988)
Update date:2022-09-26
Topics: Chemical Synthesis Clinical Trials Regulatory Approval Pharmacokinetic Studies Toxicity and Safety Evaluation Biological Activity Testing Spectroscopic Characterization
Howson, W.
Kitteringham, J.
Mistry, J.
Mitchell, M. B.
Novelli, R.
et al.
6-<4-<3-<<2-Hydroxy-3-<4-<2-(cyclopropylmethoxy)ethyl>phenoxy>propyl>amino>propionamido>phenyl>-5-methyl-4,5-dihydro-3(2H)-pyridazinone (3) consists of a mixture of four stereoisomers, i.e., two racemates, as aconsequence of the two asymmetric centers con
View MoreShenzhen Feiming Science and Technology Co,. Ltd
Contact:+86-755-85232577
Address:#B2309, Fenglin International Center ,Jixiang Road, Longcheng street, LongGang District, Shenzhen city, Guangdong province, China.
Buffett (China) Holding Co.,Ltd
Contact:4006570891
Address:
Shandong Xiangde Biotechnology Co., Ltd
Contact:+86 -15066639877
Address:Sanba street
Contact:+86-21-54391580
Address:Room 502,No.65,Lane 2388 Hongxin Road,Shanghai,China
Shandong Hongxiang Zinc Co., Ltd
Contact:086-0311-66187879
Address:DaWang developing zone
Doi:10.1021/jo01074a027
(1960)Doi:10.1002/(SICI)1096-9063(199911)55:11<1116::AID-PS65>3.0.CO;2-Y
(1999)Doi:10.1016/j.tet.2008.10.109
(2009)Doi:10.1021/jo800950y
(2008)Doi:10.1021/ja710749q
(2008)Doi:10.1016/j.bmc.2015.08.005
(2015)
